This led to the conclusion that the absence of FLNa could serve as a prognostic marker to assess the risk of breast cancer metastasis and that targeting FLNa expression might offer a therapeutic strategy to reduce tumor metastasis in affected patients [42]. Here, FLNA is linked to breast carcinoma.